RESULTS	Significantly higher 48-week response rates ( viral load < 50 copies/ml , intent-to-treat-time-to-loss-of-virological response ) were observed with rilpivirine vs. efavirenz [ 90 vs. 84 % , respectively ; difference 6.6 % ( 95 % confidence interval 1.6-11 .5 % ) ] .\